Suppr超能文献

使用指示剂稀释技术对心肌蛋白周转率进行体内测量。

In vivo measurement of myocardial protein turnover using an indicator dilution technique.

作者信息

Revkin J H, Young L H, Stirewalt W S, Dahl D M, Gelfand R A, Zaret B L, Barrett E J

机构信息

Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn. 06510.

出版信息

Circ Res. 1990 Oct;67(4):902-12. doi: 10.1161/01.res.67.4.902.

Abstract

We applied a nondestructive tracer technique, previously developed for measuring skeletal muscle protein turnover, to the measurement of myocardial protein turnover in vivo. During a continuous infusion of L-[ring-2,6-3H]phenylalanine to anesthetized, overnight-fasted dogs, we measured the uptake of radiolabeled phenylalanine from plasma and the release of unlabeled phenylalanine from myocardial proteolysis using arterial and coronary sinus catheterization and analytic methods previously applied to skeletal muscle. Using these measurements, together with a model of myocardial protein synthesis that assumes rapid equilibration of tracer specific activity between myocardial phenylalanyl-tRNA and circulating phenylalanine, we estimated the rates of heart protein synthesis and degradation. The rate of heart protein synthesis was also estimated directly from the incorporation of labeled phenylalanine into tissue protein. The use of [3H]phenylalanine was compared with L-[1-14C]leucine in the measurement of heart protein turnover in dogs given simultaneous infusion of both tracers. Leucine uptake and release by the myocardium exceeded that of phenylalanine by 3.1 +/- 0.4- and 1.7 +/- 0.3-fold, respectively, consistent with leucine's 2.4-fold greater abundance in heart protein and its metabolism via other pathways. Phenylalanine is the preferred tracer for use with this method because of its limited metabolic fate in muscle. One theoretical limitation to the method, slow equilibration of circulating labeled phenylalanine with myocardial phenylalanyl-tRNA, was resolved by comparison of these specific activities after a 30-minute infusion of labeled phenylalanine in the rat. A second, empirical limitation involves precision in the measurement of the small decrements in phenylalanine specific activity that occur with each pass of blood through the coronary circulation. This was addressed by improving the precision of both the measurements of phenylalanine concentration and phenylalanine specific activity using high-performance liquid chromatography. We conclude that the in vivo measurement of phenylalanine tracer exchange across the myocardium permits the nondestructive estimation of heart protein turnover in the intact animal.

摘要

我们将先前开发的用于测量骨骼肌蛋白质周转的非破坏性示踪技术应用于体内心肌蛋白质周转的测量。在向麻醉的、禁食过夜的狗持续输注L-[环-2,6-³H]苯丙氨酸的过程中,我们使用动脉和冠状窦插管以及先前应用于骨骼肌的分析方法,测量了血浆中放射性标记苯丙氨酸的摄取以及心肌蛋白水解中未标记苯丙氨酸的释放。利用这些测量结果,结合一个心肌蛋白质合成模型(该模型假定心肌苯丙氨酰-tRNA与循环苯丙氨酸之间的示踪剂比活性能快速平衡),我们估算了心脏蛋白质合成和降解的速率。心脏蛋白质合成的速率也可直接通过标记苯丙氨酸掺入组织蛋白来估算。在同时输注两种示踪剂的狗中,比较了[³H]苯丙氨酸和L-[1-¹⁴C]亮氨酸在测量心脏蛋白质周转中的应用。心肌对亮氨酸的摄取和释放分别比苯丙氨酸高出3.1±0.4倍和1.7±0.3倍,这与亮氨酸在心脏蛋白质中的丰度高2.4倍及其通过其他途径的代谢情况一致。由于苯丙氨酸在肌肉中的代谢途径有限,因此它是该方法的首选示踪剂。该方法的一个理论局限性是循环标记苯丙氨酸与心肌苯丙氨酰-tRNA的平衡缓慢,通过在大鼠中输注标记苯丙氨酸30分钟后比较这些比活性得以解决。第二个经验性局限性涉及测量每次血液通过冠状循环时苯丙氨酸比活性的微小下降的精度。通过使用高效液相色谱提高苯丙氨酸浓度和苯丙氨酸比活性测量的精度来解决这一问题。我们得出结论,体内测量苯丙氨酸示踪剂在心肌中的交换允许在完整动物中对心脏蛋白质周转进行非破坏性估算。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验